Wheeler Bio Speeds Up and Simplifies the Discovery-to-IND Process.
Wheeler Bio brings biologics drug innovators, discovery CROs, and CDMOs together to solve an outdated industry bottleneck with a unique partnering model, built on shared success and lasting collaborations. The typical momentum drop between discovery and development poses significant challenges for emerging biopharma companies adding technical, financial, and regulatory risks. We believe these lifecycle challenges can be reduced with more democratization of manufacturing platforms.
Wheeler is proud to currently offer best-in class mammalian cell line development, GLP material supply, and an efficient path to GMP. Connect with our team today to learn more about how Wheeler can add value to your project.

Get to IND Faster with Portable CMC™
With Portable CMC™, Wheeler is simplifying the connection between drug discovery and clinical manufacturing by standardizing and democratizing the innovation-to-impact process. A new bridge for translating discoveries to IND filing, innovators benefit from increased momentum during technology transfer and shorter timelines.
Learn MoreMedia & Events
A Biomanufacturing Ecosystem
-
Transient Protein Production
-
Stable Cell Line Development
-
Preclinical Material Supply & Testing from Stable Pools
-
Process Development & Optimization
-
Process Characterization
-
Analytical Development & Qualifications
-
Formulation Development
-
Preclinical Material Supply & Testing from Stable Clones
-
GMP Drug Substance Manufacturing (Coming in Spring 2023)
-
Molecular Biology
-
Transient Protein Production
-
Preclinical Material Supply & Testing from Stable Pools
-
Advanced Cell Line Engineering
Proven Successes
Push Boundaries. Affect Change.
We are a growing team of drug development professionals who share a passion for speed to clinical impact through collaboration.